After 12 months of treatment, people who took: Tirzepatide lost an average of 15% of their body weight Semaglutide lost an average of 8% of their body weight While the potential weight loss outcomes with both drugs are promising, these medications arent a cure-all
These activities result in a steep decline of glucose levels in blood and rapid weight loss, which are probably the chief factors behind the cardiovascular risk reduction observed in the SELECT trial
Out of all the options, the Lenreey GIP+GLP-1 Nano Microneedle Patch turned out to be the best choice
In fact, my intelligence, and I want to hear from Peter, is that this President is even doubling down on some of these issues, like hes trying to bring in like international price indexing, or most favored nation pricing and things like that, which makes it even more difficult for pharma companies to predict the future, not only from a financial standpoint, but also a regulatory standpoint, to make investments